234 related articles for article (PubMed ID: 9557250)
21. [Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
Kaiser E
Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):738-42. PubMed ID: 2948866
[TBL] [Abstract][Full Text] [Related]
22. [Oral contraceptives, risks and hazards].
Revuz J
Ann Dermatol Venereol; 2014 Jan; 141(1):5-6. PubMed ID: 24461087
[No Abstract] [Full Text] [Related]
23. [Hirsutism].
van Zuuren EJ; Pijl H
Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy of oral contraceptives on acne. Apropos of a comparative study of Varnoline vs Diane in 69 women with acne].
Levrier M; Degrelle H; Bestaux Y; Bourry-Moreno M; Brun JP; Sailly F
Rev Fr Gynecol Obstet; 1988; 83(7-9):573-6. PubMed ID: 2973646
[TBL] [Abstract][Full Text] [Related]
25. [The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
Gollnick H; Albring M; Brill K
Ann Endocrinol (Paris); 1999 Sep; 60(3):157-66. PubMed ID: 10520404
[TBL] [Abstract][Full Text] [Related]
26. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Franks S; Layton A; Glasier A
Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
[TBL] [Abstract][Full Text] [Related]
27. [Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive].
Mehrl J
Fortschr Med; 1988 Aug; 106(25):50-1. PubMed ID: 2971600
[No Abstract] [Full Text] [Related]
28. Endocrine aspects of acne.
Lucky AW
Pediatr Clin North Am; 1983 Jun; 30(3):495-9. PubMed ID: 6224126
[TBL] [Abstract][Full Text] [Related]
29. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
Lemay A; Dewailly SD; Grenier R; Huard J
J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
[TBL] [Abstract][Full Text] [Related]
30. [Acne vulgaris: endocrine aspects].
Dekkers OM; Thio BH; Romijn JA; Smit JW
Ned Tijdschr Geneeskd; 2006 Jun; 150(23):1281-5. PubMed ID: 16821451
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate.
Vartiainen M; de Gezelle H; Broekmeulen CJ
Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476
[TBL] [Abstract][Full Text] [Related]
32. [Clinical use of ethinyl estradiol in combination with cyproterone acetate. Study based on 50 cases (author's transl)].
Henrion R; Laveissiere MN
Contracept Fertil Sex (Paris); 1982 Oct; 10(10):653-7. PubMed ID: 12338447
[TBL] [Abstract][Full Text] [Related]
33. New developments in hormonal therapy for acne.
Tan JK
Skin Therapy Lett; 2007 Sep; 12(7):1-3. PubMed ID: 17940710
[TBL] [Abstract][Full Text] [Related]
34. Practical approach to the hormonal treatment of acne.
Poulin Y
J Cutan Med Surg; 2004; 8 Suppl 4():16-21. PubMed ID: 15778820
[TBL] [Abstract][Full Text] [Related]
35. The use of hormonal agents in the treatment of acne.
Hassoun LA; Chahal DS; Sivamani RK; Larsen LN
Semin Cutan Med Surg; 2016 Jun; 35(2):68-73. PubMed ID: 27416311
[TBL] [Abstract][Full Text] [Related]
36. [Dermatologic therapy unit anti-androgens].
Nolting S
Fortschr Med; 1977 Mar; 95(12):825-8. PubMed ID: 140141
[TBL] [Abstract][Full Text] [Related]
37. Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: a randomized controlled trial.
Leelaphiwat S; Jongwutiwes T; Lertvikool S; Tabcharoen C; Sukprasert M; Rattanasiri S; Weerakiet S
J Obstet Gynaecol Res; 2015 Mar; 41(3):402-10. PubMed ID: 25319761
[TBL] [Abstract][Full Text] [Related]
38. [Differentiated application of oral contraceptives basing on the different side effects of synthetic progestins (author's transl)].
Braendle W; Leidenberger F
Ther Umsch; 1976 Apr; 33(4):231-3. PubMed ID: 137547
[TBL] [Abstract][Full Text] [Related]
39. Anti-androgens in treatment of acne vulgaris.
Amer M; Ramadan A; Abdel Monem A
Int J Dermatol; 1985 Oct; 24(8):533-4. PubMed ID: 2933345
[TBL] [Abstract][Full Text] [Related]
40. [Hormonal factors in etiology of common acne].
Bergler-Czop B; Brzezińska-Wcisło L
Pol Merkur Lekarski; 2004 May; 16(95):490-2. PubMed ID: 15518435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
